← All candidates
88 insider filings on record.
Josh GottheimerIntelligence · Financial Servicestraded 19 Nov 2025 · filed 29 Dec 2025 · jointSell$1K–$15Kjoint19 Nov 2025301d ago29 Dec 2025261d ago88 filings on record.
EWEdwards Lifesciences Corp
NYSE · Healthcare · $49.42B
$85.74
+0.26% · Sep 15
88 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 38 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$49.42B
Float
574.5M
100% public
Short % float
Pro
Price / profit
51.0
Price / future profit
25.4
Price / sales
7.6
Congress
▸ Disclosures lag trades by 30–45 days.
1 disclosure12 mo
MemberTypeAmountOwnerTradedFiled
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
83 more transactions on Pro →Context
Wall St
$97.15 avg target
+13.3% vs today · 27 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26$0.78 act+$0.05
Q4 '25$0.58 act−$0.04
Q3 '25$0.67 act+$0.08
Q2 '25$0.67 act+$0.05
Coverage
Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?Barchart · 05-14Edwards Lifesciences' (NYSE:EW) Conservative Accounting Might Explain Soft EarningsSimply Wall St. · 05-13Edwards Lifesciences (EW) is Benefitting from Expanding Its Aortic Valve FranchiseInsider Monkey · 05-11Edwards names Theodora Mistras as CFOMedTech Dive · 05-05
The file stays open
88 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice